Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5356 studies found for:    MS
Show Display Options
Rank Status Study
1 Recruiting Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome
Condition: Multiple Sclerosis
Interventions: Drug: Vitamin D;   Drug: Placebo;   Other: Imaging;   Biological: Lumbar puncture;   Biological: Blood sampling;   Biological: Urine samples
2 Completed A Phase I/II Study of GX15-070MS in Untreated CLL
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: GX15-070MS
3 Completed
Has Results
Oral Cladribine in Early Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: Cladribine;   Drug: Placebo;   Drug: Rebif® new formulation (RNF)
4 Recruiting Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients
Condition: Multiple Sclerosis (MS)
Intervention:
5 Unknown  Is MS14 Helpful in Schizophrenia?
Condition: Schizophrenia
Interventions: Drug: MS14;   Drug: Risperidone
6 Completed Therapy Optimization in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
7 Completed Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Condition: Multiple Sclerosis (MS)
Intervention: Drug: H.P. Acthar Gel (repository corticotropin injection)
8 Completed Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: colecalciferol
9 Enrolling by invitation Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)
Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
10 Completed Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects
Condition: Healthy
Interventions: Drug: BIBR 1048 MS Capsule E;   Drug: BIBR 1048 MS Capsule F;   Drug: BIBR 1048 MS Capsule G;   Drug: BIBR 1048 MS Tablet H;   Drug: BIBR 1048 MS Drinking solution;   Drug: Pantoprazole
11 Completed Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects
Condition: Healthy
Interventions: Drug: BIBR 1048 MS Capsule I;   Drug: BIBR 1048 MS Capsule K;   Drug: Pantoprazole;   Drug: BIBR 1048 MS drinking solution
12 Completed AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
Conditions: Multiple Sclerosis;   Clinically Isolated Syndrome
Intervention:
13 Completed Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin
Condition: Healthy
Interventions: Drug: BIBR 1048 MS;   Drug: Placebo of BIBR 1048 MS
14 Active, not recruiting Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
15 Completed Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers
Condition: Healthy
Interventions: Drug: BIBR 1048 MS low;   Drug: BIBR 1048 MS medium 1;   Drug: BIBR 1048 MS medium 2;   Drug: BIBR 1048 MS high;   Drug: BIBR 1048 MS placebo
16 Completed Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers
Condition: Healthy
Interventions: Drug: BIBR 1048 MS dose 1;   Drug: BIBR 1048 MS dose 2;   Drug: BIBR 1048 MS dose 3;   Drug: BIBR 1048 MS dose 4;   Drug: BIBR 1048 MS dose 5;   Drug: Placebo to BIBR 1048 MS
17 Active, not recruiting Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
Conditions: Multiple Sclerosis (MS);   Relapsing-Remitting MS;   Primary Progressive MS;   Secondary Progressive MS;   Clinically Isolated Syndrome (CIS)
Intervention: Other: No study treatments administered - blood draws only
18 Completed Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin
Condition: Healthy
Interventions: Drug: BIBR 1048 MS low dose;   Drug: BIBR 1048 MS medium dose;   Drug: BIBR 1048 MS high dose
19 Completed Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects
Condition: Healthy
Interventions: Drug: BIBR 1048 MS  - low dose;   Drug: BIBR 1048 MS  - high dose;   Drug: BIBR 1048 MS + Pantoprazole
20 Recruiting Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Device: Neuromodulation Rehabilitation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years